NCT00583232View on ClinicalTrials.gov

Protein and Energy Metabolism in Pediatric Crohn's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Crohn's DiseaseProtein MetabolismEnergy Metabolism
Interventions
DRUG

Stable isotope infusions

Stable isotope infusion will be given via an intravenous catheter. Subjects will receive a priming dose and a continuous dose.

Trial Locations (1)

46202

Indiana University-Riley Hospital for Children, Indianapolis

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Crohn's and Colitis Foundation

OTHER

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Indiana University

OTHER